Article Text

Download PDFPDF
Neonatal thrombocytopenia: causes and management
  1. I Roberts,
  2. N A Murray
  1. Imperial College, Hammersmith Campus, London W12 0NN, UK
  1. Correspondence to:
    Dr Roberts, Department of Haematology, Hammersmith Campus, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK;


Neonatal thrombocytopenia is a common clinical problem. Thrombocytopenia presenting in the first 72 hours of life is usually secondary to placental insufficiency and caused by reduced platelet production; fortunately most episodes are mild or moderate and resolve spontaneously. Thrombocytopenia presenting after 72 hours of age is usually secondary to sepsis or necrotising enterocolitis and is usually more severe and prolonged. Platelet transfusion remains the only treatment. There is a need for trials to define the safe lower limit for platelet count and which neonates will benefit from treatment.

  • interleukin 11
  • platelets
  • preterm
  • thrombocytopenia
  • NICU, neonatal intensive care unit
  • NEC, necrotising enterocolitis
  • NAITP, neonatal alloimmune; thrombocytopenia
  • HPA, human platelet antigen
  • ICH, intracranial haemorrhage
  • IVIG, intravenous immunoglobulin
  • Tpo, thrombopoietin
  • IL, interleukin
  • rh, recombinant human

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.